mortality/aging
|
• similar to in mice expressing Tg(TRAMP)8247Ng, survival is reduced to 26 to 28 weeks unlike in wild-type mice
|
neoplasm
|
• mice develop prostate and genitourinary tract masses unlike wild-type mice but at a 10% reduced occurrence compared to in Tg(TRAMP)8247Ng expressing mice
|
|
• mice develop prostate masses unlike wild-type mice but at a 10% reduced occurrence compared to in Tg(TRAMP)8247Ng expressing mice
|
reproductive system
|
• mice develop prostate masses unlike wild-type mice but at a 10% reduced occurrence compared to in Tg(TRAMP)8247Ng expressing mice
|
endocrine/exocrine glands
|
• mice develop prostate masses unlike wild-type mice but at a 10% reduced occurrence compared to in Tg(TRAMP)8247Ng expressing mice
|